CoreCap Advisors’s Bio-Techne TECH Stock Holding History

CoreCap Advisors’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.54K	Sell	36 -2	-5%	-$108	﹤0.01%	2482
2026 Q1	$1.99K	Sell	38 -26	-41%	-$1.56K	﹤0.01%	2416
2025 Q4	$3.78K	Sell	64 -60	-48%	-$3.65K	﹤0.01%	2304
2025 Q3	$6.91K	Hold	124	–	–	﹤0.01%	2087
2025 Q2	$6.39K	Sell	124 -27	-18%	-$1.36K	﹤0.01%	2043
2025 Q1	$8.86K	Sell	151 -321	-68%	-$21.8K	﹤0.01%	1870
2024 Q4	$34K	Sell	472 -71	-13%	-$5.21K	﹤0.01%	1339
2024 Q3	$43.4K	Sell	543 -1	-0.2%	-$75	﹤0.01%	1252
2024 Q2	$39K	Buy	544 +1	+0.2%	+$74	﹤0.01%	723
2024 Q1	$38.2K	Buy	+543	New	+$38.9K	﹤0.01%	1213
2022 Q4	$124K	Buy	+1,500	New	+$119K	0.01%	656
2022 Q3	–	Sell	-1,688	Closed	-$146K	–	1918
2022 Q2	$146K	Sell	1,688 -384	-19%	-$36K	0.01%	586
2022 Q1	$224K	Sell	2,072 -2,792	-57%	-$288K	0.02%	482
2021 Q4	$629K	Buy	+4,864	New	+$596K	0.04%	317

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

CoreCap Advisors's TECH Position: Q2 2026 in Review

CoreCap Advisors reduced its Bio-Techne (TECH) stake by 5.3% in Q2 2026, selling an estimated $108 and leaving 36 shares worth $2.54K. The position accounts for ﹤0.01% of the portfolio, ranked #2482.

CoreCap Advisors first reported a position in TECH in Q4 2021 and has held it in 14 quarters since. The position peaked at $629K in Q4 2021. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

CoreCap Advisors held 36 shares of Bio-Techne worth $2.54K as of Q2 2026.
CoreCap Advisors sold 2 Bio-Techne shares in Q2 2026, an estimated $108.
Bio-Techne made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #2482 holding.
CoreCap Advisors first reported a position in Bio-Techne in Q4 2021 and has held it in 14 quarters since.
CoreCap Advisors's Bio-Techne position peaked at $629K in Q4 2021.
596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.